A Phase I Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA) in Children with Relapsed Refractory Solid Tumors

Grant

Date/time Interval

  • November 18, 2014 - November 17, 2018
  • Total Award Amount

  • 22500.00
  • Direct Costs

  • 17857.00
  • Sponsor Award Id

  • Contributor

  • Galtarossa Xavier, Ana   Investigator